Karyopharm Therapeutics reported $301.57M in Loan Capital for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Loan Capital Change
Acceleron Pharma XLRN:US $ 0M 0M
Amgen AMGN:US $ 33291M 4833M
Astrazeneca AZN:US 28.94B 4.34B
AstraZeneca AZN:LN 28939M 4338M
Avrobio Inc AVRO:US $ 0 0
Bristol Myers Squibb BMY:US $ 39677M 2826M
Eli Lilly And LLY:US $ 15522.4M 785.8M
Epizyme EPZM:US $ 231.83M 640K
GlaxoSmithKline GSK:LN 20736M 294M
Karyopharm Therapeutics KPTI:US $ 301.57M 195K
Macrogenics MGNX:US $ 0 0
Mirati Therapeutics MRTX:US $ 0M 0M
Nektar Therapeutics NKTR:US $ 0M 0M
Novartis NVS:US $ 24715M 1776M
Novartis NOVN:VX SF 24715M 1776M
Regeneron Pharmaceuticals REGN:US $ 1979.6M 0.4M
Sangamo Biosciences SGMO:US $ 0M 0M
Takeda 4502:JP Y 4016473M 365116M
Ultragenyx Pharmaceutical RARE:US $ 0M 0M
Xencor XNCR:US $ 0M 0M
YTE INCY:US $ 31.38M 0.46M